- DocGo, that is to be merged with Motion Acquisition (NASDAQ:MOTN), announced that its business line Rapid Reliable Testing is working with Carnival Corporation on COVID-19 testing and COVID-19 vaccines for crew members.
- Carnival prepares for the restart of cruising in the U.S., and plans to also test guests once cruises resume.
- RRT is facilitating on-site antigen tests, also known as rapid diagnostic tests, for all crew on 18 ships in the company's fleet, an effort that may expand to additional ships.
- Related (May 27): DocGo, to be merged with Motion Acquisition, partners with Barclays Center.